ROS1 and non-small cell lung carcinoma: In this study, we assayed and investigated the status of EGFR, KRAS, MET, ALK, ROS1, HER2, RET, BRAF, NRAS, and PIK3CA somatic driver gene alterations derived from 851 Chinese NSCLC patients.